These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19071103)

  • 1. A diagnostic model to differentiate simple steatosis from nonalcoholic steatohepatitis based on the likelihood ratio form of Bayes theorem.
    Sookoian S; Castaño G; Burgueño AL; Gianotti TF; Rosselli MS; Pirola CJ
    Clin Biochem; 2009 May; 42(7-8):624-9. PubMed ID: 19071103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.
    Palekar NA; Naus R; Larson SP; Ward J; Harrison SA
    Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis.
    Shimada M; Kawahara H; Ozaki K; Fukura M; Yano H; Tsuchishima M; Tsutsumi M; Takase S
    Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.
    Wieckowska A; Zein NN; Yerian LM; Lopez AR; McCullough AJ; Feldstein AE
    Hepatology; 2006 Jul; 44(1):27-33. PubMed ID: 16799979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease.
    Miele L; Forgione A; La Torre G; Vero V; Cefalo C; Racco S; Vellone VG; Vecchio FM; Gasbarrini G; Rapaccini GL; Neuman MG; Grieco A
    Transl Res; 2009 Oct; 154(4):194-201. PubMed ID: 19766963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
    Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
    Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian approach to an integrated multimodal noninvasive diagnosis of definitive nonalcoholic steatohepatitis in the spectrum of nonalcoholic fatty liver disease.
    Yilmaz Y; Eren F
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1292-5. PubMed ID: 25171027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis.
    Chen C; Schmilovitz-Weiss H; Liu XE; Pappo O; Halpern M; Sulkes J; Braun M; Cohen M; Barak N; Tur-Kaspa R; Vanhooren V; Van Vlierberghe H; Libert C; Contreras R; Ben-Ari Z
    J Proteome Res; 2009 Feb; 8(2):463-70. PubMed ID: 19140676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
    Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
    Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Likelihood ratios of clinical, laboratory and image data of pancreatic cancer: Bayesian approach.
    de Icaza E; López-Cervantes M; Arredondo A; Robles-Díaz G
    J Eval Clin Pract; 2009 Feb; 15(1):62-8. PubMed ID: 19239583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.
    Lee JH; Kim D; Kim HJ; Lee CH; Yang JI; Kim W; Kim YJ; Yoon JH; Cho SH; Sung MW; Lee HS
    Dig Liver Dis; 2010 Jul; 42(7):503-8. PubMed ID: 19766548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FibroMAX: towards a new universal biomarker of liver disease?
    Morra R; Munteanu M; Imbert-Bismut F; Messous D; Ratziu V; Poynard T
    Expert Rev Mol Diagn; 2007 Sep; 7(5):481-90. PubMed ID: 17892356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging.
    Elias J; Altun E; Zacks S; Armao DM; Woosley JT; Semelka RC
    Magn Reson Imaging; 2009 Sep; 27(7):976-87. PubMed ID: 19356874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study.
    Polyzos SA; Kountouras J; Slavakis A; Zafeiriadou E; Patsiaoura K; Katsiki E; Zavos C; Papatheodorou A; Terpos E
    Biomarkers; 2013 Nov; 18(7):607-13. PubMed ID: 24041134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathology of nonalcoholic steatohepatitis].
    Jeen YM; Jin SY
    Korean J Hepatol; 2009 Jun; 15(2):122-30. PubMed ID: 19581764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.
    Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Yerci O; Oral AY; Gul CB; Gurel S; Nak SG; Gulten M
    Med Sci Monit; 2009 Apr; 15(4):CR189-93. PubMed ID: 19333204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.
    Younossi ZM; Afendy A; Stepanova M; Hossain N; Younossi I; Ankrah K; Gramlich T; Baranova A
    Liver Int; 2009 Oct; 29(9):1403-12. PubMed ID: 19515216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
    Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and diagnostic accuracy of 5 physical examination tests and combination of tests for subacromial impingement.
    Michener LA; Walsworth MK; Doukas WC; Murphy KP
    Arch Phys Med Rehabil; 2009 Nov; 90(11):1898-903. PubMed ID: 19887215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.